Claim your CME credit at https://reachmd.com/programs/cme/jak-inhibitor-therapy-for-alopecia-areata-expert-guidance-to-fill-in-the-gaps/16627/
The treatment landscape for alopecia areata is shifting with the recent FDA approval of 2 JAK inhibitors and a robust development pipeline. Tune in to this CME-certified, on-demand activity for the latest insights about pathophysiology, diagnosis, management, and much more from renowned dermatology experts.
=